You may have seen this headline last week: “World Health Organization says new virus may be ‘threat to entire world.‘” And if you’re like me, you may have been surprised by your own ho-hum reaction. Is this a crying-wolf situation? Have we been warned about too many potentially scary viruses over the last few years? Or are we just getting more used to living with viral uncertainty? Here, Dr. Paul Sax, clinical director of the Division of Infectious Diseases at Brigham and Women’s Hospital, writes about his own reaction to this latest outbreak in the face of insufficient information.
By Dr. Paul E. Sax
And here’s his email:
Concerned? Terrified? I bet your department is buzzing about this.
Um, not quite — especially since, among the 49 cases in the world (apparently there are five more than the WHO reported), exactly zero have occurred thus far in the United States. As of May 29, 2013, it hasn’t even cracked the front page of the CDC site.
Is MERS-CoV — short for Middle East Respiratory Syndrome Coronavirus — potentially of great concern? Of course. The WHO response seems right, especially with the parallels to SARS.
But do we garden-variety infectious disease specialists know how serious it will be on a global basis? Of course not. As with the first SARS cases, the first anthrax cases, the first West Nile cases, the first hantavirus cases, even the first AIDS cases — we really don’t have enough points on the graph yet to make any sort of confident predictions.
And from a practical perspective, the clinical unfamiliarity doesn’t help. If someone walked into our emergency room tomorrow with fever, cough, and respiratory symptoms, would we know how to distinguish MERS-CoV — from the hundreds (OK, thousands) of other causes of similar illnesses?
Initially, not a chance. The denominator of people with these complaints is just too gargantuan. It will probably take someone with a particularly severe respiratory illness, along with the appropriate exposure (“He just returned from a 10-day business trip to Riyadh”) for an astute clinician to make the connection.
So how should we infectious disease doctors, who are supposed to know everything, respond to these emails in the interim? Continue reading